ライフサイエンスコーパス: exclusion criteria

1 cytes by dependence on the kinase TAK1 and rigorous lineage-exclusion criteria.

2 number of IR patients that do not meet the strict inclusion/exclusion criteria.

3 nth follow-up were included in the study after applying the exclusion criteria.

4 Meta-Analyses guidelines was prepared for the inclusion and exclusion criteria.

5 s were analyzed in detail using predetermined inclusion and exclusion criteria.

6 es among the subgroup of patients meeting the inclusion and exclusion criteria.

7 SE from inception to January 2016 and applied predetermined exclusion criteria.

8 All consenting patients were included, with no exclusion criteria.

9 (87% of screening assessments) rather than meeting specific exclusion criteria (52% of screening assessments).

10 otal of 94 patients were enrolled, of whom 44 met inclusion/exclusion criteria and were randomized to the IASD (n=22) and

11 Exclusion criteria consisted of IVB treatment prior to the st

12 Exclusion criteria consisted of suicidal or homicidal intent

13 EXCLUSION CRITERIA: fluorescence in situ hybridization, fluor

14 We examined the inclusion and exclusion criteria for each randomized controlled trial and t

15 ictor variables in populations that satisfied inclusion and exclusion criteria for each rule (validation cohort).

16 We used the same inclusion and exclusion criteria for the replication set.

17 We show empirical evidence for exclusion criteria for underperforming probes, providing a so

18 Exclusion criteria included a full-thickness torn rotator cuf

19 Exclusion criteria included any comorbidity or laboratory abn

20 Exclusion criteria included bilateral breast cancer, previous

21 Exclusion criteria included current smokers or former smokers

22 Exclusion criteria included eosinophilic oesophagitis and sev

23 Exclusion criteria included obesity (body mass index [BMI] >3

24 Exclusion criteria included open fractures, fractures involvi

25 Exclusion criteria included previous pasireotide treatment, m

26 Exclusion criteria included prior EGFR-TKI use, EGFR-TKI resi

27 Key exclusion criteria included: CNS involvement, a stroke or int

28 Exclusion criteria included: no intravenous fluids >/=48 hour

29 Results Thirty-two studies met inclusion and exclusion criteria, including 3524 imaging examinations: 1963

30 REVIEW Using the predetermined inclusion/exclusion criteria, nine reviewers working in pairs assessed

31 ized controlled trials (RCTs) are based on strict inclusion/exclusion criteria, non-interventional studies (NISs) might p

32 After filtering out compounds based on exclusion criteria, such as toxicity, 36 drugs were retained.

33 Exclusion criteria were an active infection or fistula, antib

34 Inclusion and exclusion criteria were applied by 2 independent coders with

35 admissions (10%) were eligible for analysis once predefined exclusion criteria were applied: 4,804 (31.7%) received "noni

36 Exclusion criteria were date of diagnosis before 2007 or afte

37 Exclusion criteria were diabetes mellitus, history of stroke,

38 Given the rarity of patient-matched samples, no exclusion criteria were enacted.

39 Exclusion criteria were gestational age <32 weeks, birth weig

40 Exclusion criteria were gestational age of less than 32 weeks

41 Exclusion criteria were intraocular involvement, orbital lymp

42 Exclusion criteria were missing data for either race or initi

43 Exclusion criteria were missing key data, death sooner than 2

44 Exclusion criteria were neoadjuvant treatment or pancreatitis

45 s AKI stages 1 to 3 (Acute Kidney Injury Network criteria), exclusion criteria were obstructive uropathy, urothelial carc

46 Exclusion criteria were patients less than 18 years of age an

47 Exclusion criteria were previous surgery, other corneal condi

48 Exclusion criteria were the presence of other ocular patholog

49 Exclusion criteria were the use of illicit psychotropic subst

50 Main exclusion criteria were: symptoms for longer than 3 weeks, th